MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with B

Budesonide + Formoterol

Budesonide 100micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler

Unsuitable

Stability notes for Budesonide 100micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler

There are no stability notes for this medicine.

Suppliers

Symbicort 100/6 Turbohaler (AstraZeneca UK Ltd)
Symbicort 100/6 Turbohaler (Necessity Supplies Ltd)
Symbicort 100/6 Turbohaler (Sigma Pharmaceuticals Plc)

Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler

Unsuitable

Stability notes for Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler

There are no stability notes for this medicine.

Suppliers (4) of Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler
Symbicort 200/6 Turbohaler (AstraZeneca UK Ltd)
Symbicort 200/6 Turbohaler (CST Pharma Ltd)
Symbicort 200/6 Turbohaler (Pharmaram Ltd)
Symbicort 200/6 Turbohaler (Sigma Pharmaceuticals Plc)

Budesonide 400micrograms/dose / Formoterol 12micrograms/dose dry powder inhaler

Unsuitable

Stability notes for Budesonide 400micrograms/dose / Formoterol 12micrograms/dose dry powder inhaler

There are no stability notes for this medicine.

Suppliers (5) of Budesonide 400micrograms/dose / Formoterol 12micrograms/dose dry powder inhaler
Symbicort 400/12 Turbohaler (AstraZeneca UK Ltd)
Symbicort 400/12 Turbohaler (CST Pharma Ltd)
Symbicort 400/12 Turbohaler (Necessity Supplies Ltd)
Symbicort 400/12 Turbohaler (Pharmaram Ltd)
Symbicort 400/12 Turbohaler (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.